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In this study, we performed a new bioactive glass formulation with the molar composition 64 % SiO2 - 31 % CaO - 5 %
P2O5 by the sol-gel method. Sol-gel derived bioglass material was produced in nanopowder using planetary milling machine, 
followed by sintering at 700°C, for applications as bioactive material in bioactive scaffolds or in orthopaedic. The obtained 
material was evaluated by X-ray powder diffraction (XRD), thermal gravimetric analysis (TGA), differential scanning calo-
rimetry (DSC) analyses, Fourier transform infrared spectroscopy (FTIR), scanning electron microscope (SEM) and nitrogen 
adsorption pore size. The biocompatibility evaluation of the formed glass was assessed through in vitro cell culture by 
evaluation of alkaline phosphatase activity of osteoblasts and immersion studies in simulated body fluid (SBF) for different 
time intervals while monitoring the pH changes and the concentration of calcium, phosphorus and silicon in the SBF medium 
as key factors in the rapid bonding of this bioactive glass to bone tissue as a high bioactive glass. The present investigation 
revealed that the sol-gel derived ternary bioglass system has the ability to support the growth of human fetal osteoblastic 
cells (hFOB 1.19). Finally, this material proved to be non-toxic and compatible for the proposed work in segmental defects 
in the goat model in vivo.
INTRODUCTION
  During the last decade considerable attention has 
been  directed  towards  the  use  of  bioactive  materials, 
where  bioactivity  is  defined  as  interfacial  bonding  of 
an implant or a bioactive scaffold to tissue by means 
of  formation  of  a  biologically  active  hydroxyapatite 
layer on the bioactive material surface [1-3]. At present, 
it  is  possible  to  develop  some  new  biomaterials  due 
to  extensive  overlaps  between  sol-gel  chemistry  and 
biochemistry. Many kind of bioactive materials including 
bioglasses [4], bioglass–ceramics [5], and calcium phos-
phate ceramics [6], have been developed and some of 
them are now applied to repair and reconstruct diseased 
or damaged bones or tissue engineering. Bioactive ma-
terials  elicit  a  specific  biological  response  at  the  in- 
terface  of  the  material  leading  to  the  formation  of  a 
natural bond and development of new mineralized bone 
tissue. Similarly bioactive glasses have been extensively 
studied  for  more  than  thirty  years  since  Hench  first 
invented Bioglass [7]. Because of the good bioactivity, 
osteoconductivity and biodegradability [7-9], bioglasses, 
as bone repair materials or fillers owing to their ability 
to form a bond to living bone [10], have been used in 
clinic for more than ten years [11-13]. Also, Hench has 
described a sequence of five reactions that resulted in the 
formation of hydroxy apatite (HA) layer on the surface 
of these bioactive glasses [14, 15]. A bioactive glass is 
one that undergoes surface dissolution in a physiological 
environment in order to form a hydroxycarbonate apatite 
(HCA) layer [16]. The larger the solubility of a bioactive 
glass, the more pronounced is the effect on bone tissue 
growth [17].
  Adhesion, proliferation and differentiation are fun-
damental mammalian cellular processes involved in em- 
bryogenesis, immune response, tissue maintenance, and 
wound  healing  [18].  Cell  contact,  attachment,  diffe- 
rentiation and subsequent adhesion of anchorage-depen-
dent  cells  are  among  the  first  phases  of  cell–material 
interactions [19, 20] that soberly influence integration 
with tissue and eventual success or failure of a broad 
range of biomaterials in tissue engineering. Bizari D., Rabiee M., Moztarzadeh F., Tahriri M., Alavi S. H., Masaeli R.
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  In this article we have tried to focus on alkaline 
phosphate  activity  of  osteoblastic  cells  cultured  on 
bioglass  due  to  the  fact  that  one  of  the  phenotypic 
markers for osteoblast proliferation and differentiation 
is  alkaline  phosphatase  expression  which  can  assay 
by  spectrophotometry.  Improved  hard-tissue  repair, 
augmentation, or replacement has thus become a very 
significant  challenge  for  orthopedic  biomaterials  and 
orthopedic surgery. Meeting these challenges depends, 
in  part,  on  establishing  firm  relationships  between 
implant  success  and  orthopedic  biomaterial  properties 
that  can  guide  the  design  process.  These  structure–
property relationships critically depend on a thorough 
understanding  of  the  adhesion  of  hard-tissue  cells 
(osteoblasts, osteoclasts, chondrocytes, etc.) to artificial 
materials [21–23]. 
  Various  model  osteoblasts  have  been  introduced 
and used to gain insight into the bone–cell response to 
candidate  orthopedic  biomaterials  in  vitro.  The  most 
widely  used  model  cells  are  primary  cultures  derived 
from normal human and rodent bone fragments, or osteo-
sarcoma cell lines generated from human bone tumors. 
Each of these cell sources has strengths and limitations 
for  studying  the  cell  adhesion  of  osteoblasts  in  vitro 
[24–27]. In effort to overcome these limitations, Harris 
et  al.  [27]  established  a  conditionally  immortalized, 
human  fetal  osteoblast  cell  line,  hFOB  1.19  that  was 
stably transfected with a gene coding for a temperature-
sensitive mutant (tsA58) of the SV40 large T antigen. 
Resultant  hFOB  cells  express  osteoblast-specific 
phenotypic markers and mineralize extracellular matrix 
(ECM).
  In  this  Project,  we  synthesized  using  the  sol-gel 
method,  a  bioactive  glass  in  the  ternary  system  with 
molar composition: 64 % SiO2 - 31 % CaO - 5 % P2O5
(64S).  There  are  several  advantages  of  a  sol-gel-
derived glass over a melt-derived glass which are im-
portant  for  making  bioactive  materials  for  using  in 
tissue engineering. Some of these merits are such as: 
lower temperature processing, higher bioactivity, being 
interconnected  nanometer  scale  porosity  consequently 
ability to impregnated with biologically active phases 
such as growth factors, higher range of SiO2 usage (up to 
90 mole %) and lack of necessity of sodium oxide which 
is used to conventional melt-derived bioglass [8,11]. A 
key feature of bioactive materials is their ability to form 
bone like apatite on their surfaces in vivo and in vitro. In 
this study Human fetal osteoblast (hFOB 1.19) cells were 
used for the assessment of the biocompatibility of the 
bioglass powder in vitro study and the hFOB cells were 
selected for culturing due to their relatively high growth 
rates and rapid differentiation into mature osteoblasts [16, 
17, 28]. Also, the in vitro studies of apatite formation can 
carry out by soaking the glass at body temperature in an 
aqueous solution with pH and ionic composition similar 
to that of blood plasma [29]. The sequence of events 
leading to apatite formation includes release of ions from 
the glass, formation and condensation of silanol groups 
(Si-OH) on the glass surface, adsorption of calcium and 
phosphate ions to the surface to nucleate an amorphous 
calcium phosphate, and growth and crystallization of the 
calcium phosphate layer [30]. For sol-gel bioglass, the 
synthetic route and lower heating temperatures lead to 
increased numbers of silanol groups or mesopores, both 
of which may act as nucleation sites for apatite formation 
[31–35].
EXPERIMENTAL 
Materials
  Tetraethylorthosilicate  (TEOS:  C8H20O4Si),  cal-
cium  nitrate  (Ca(NO3)2.4H2O),  and  triethyl  phospha-
te  (TEP:  C6H15O4P)  and  0.1  M  nitric  acid  (HNO3) 
and  reagent-grade  chemicals  NaCl,  NaHCO3,  KCl,
K2HPO4.3H2O,  MgCl2.6H2O,  CaCl2,  trishydroxy-me-
thyl aminomethane [Tris-buffer, (CH2OH)3CNH2], and 
1 N HCl as required materials for preparation of SBF, 
were purchased from Merck I.
Sample Synthesis
  The  sol-gel-prepared  glass  materials  SiO2–P2O5–
–CaO (64 % SiO2, 5 % P2O5, and 31 % CaO), (based on 
mol %), was synthesized and characterized. The solution 
for  the  glass  was  prepared  and  described  as  follows: 
14.8 g of TEOS was added into 30 ml of 0.1 M nitric acid, 
the mixture was allowed to react for 30 min for the acid 
hydrolysis of TEOS to proceed almost to completion. 
The following reagents were added in sequence allowing 
45 min for each reagent to react completely: 0.85 g TEP, 
and  7.75  g  of  calcium  nitrate  tetrahydrate.  After  the 
final addition, mixing was continued for 1 h to allow 
completion of the hydrolysis reaction. The solution was 
cast in a cylindrical Teflon container and kept sealed for 
10 days at room temperature to allow the hydrolysis and 
a polycondensation reaction to take place until the gel 
was formed. The gel was kept in a sealed container and 
heated at 70°C for an additional 3 days. The water was 
removed and a small hole was inserted in the lid to allow 
the leakage of gases while heating the gel to 120°C for 
2 days to remove all the water. Subsequently, the powders 
were  milled  by  planetary  milling  (SVD15IG5-1,  LG 
Company) with 400 rpm during 10 h. After grinding and 
sieving, the dry powder heated 24 h at 700°C for nitrate 
elimination. Finally the powder was ground for 10 h for 
achieving bioglass nanopowder.
Preparation of SBF
  The SBF solution was prepared by dissolving rea-
gent-grade  NaCl,  KCl,  NaHCO3,  MgCl2.6H2O,  CaCl2 
and KH2PO4 into distilled water and buffered at pH 7.25 Synthesis, characterization and biological evaluation of sol–gel derived nanomaterial in the ternary system...
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with TRIS (trishydroxymethyl aminomethane) and HCl 
1N at 37°C. Its composition is given in Table 1 and is 
compared with the human blood plasma [15].
Sample characterization
XRD analysis
  The  resulting  powder  was  analyzed  by  X-ray 
diffraction (XRD) with Siemens-Brucker D5000 diffrac-
tometer. This instrument works with voltage and current 
settings of 40 kV and 40 mA respectively and uses Cu-
Ka  radiation  (1.540600  Å).  For  qualitative  analysis, 
XRD diagrams were recorded in the interval 10° ≤ 2θ ≤ 
50° at scan speed of 2°/min being the step size 0.02° and 
the step time 1 s.
TGA analysis
  The  thermogravimetric  (TG)  curve  was  obtained 
in  a  Shimadzu  TGA-50  apparatus,  under  a  nitrogen 
atmosphere that starting from room temperature up to 
1200°C with the heating rate of 5°C/min. 
DSC analysis
  The DSC curve was obtained in a Shimadzu DSC-
50 apparatus, under a nitrogen atmosphere that starting 
from room temperature up to 1200°C with the heating 
rate of 5°C/min.
FTIR analysis
  The  bioglass  powder  was  examined  by  Fourier 
transform infrared spectroscopy with Bomem MB 100 
spectrometer. For IR analysis, in first 1 mg of the powder 
samples  were  carefully  mixed  with  300  mg  of  KBr 
(infrared grade) and palletized under vacuum. Then the 
pellets were analyzed in the range of 500 to 4000 cm
−1 at 
the scan speed of 23 scan/min with 4 cm
−1 resolution.
SEM and EDX analysis
  The morphology of the synthesized bioglass was 
observed by scanning electron microscopy (SEM: Philips 
XL30). Prior to examination, the sample was coated with 
a  thin  layer  of  Gold  (Au)  by  sputtering  (EMITECH 
K450X, England). Also, energy dispersive X-ray ana-
lyzer  (EDX,  Rontec,  Germany)  directly  connected  to 
SEM was used to investigate semiquantitatively chemical 
composition of the synthesized bioglass powder.
N2 adsorption analysis
  The pore texture of the sample was analyzed with an 
automatic nitrogen adsorption pore size analyzer (Tristar 
3000,  Micromeritics)  by  N2  adsorption  method.  The 
samples were degassed in vacuum at 150°C for 18 - 20 h 
for the removal of moisture from the pores and analyzed 
with nitrogen adsorption. These analyses have provided 
the data of specific surface area, average pore size, and 
pore volume.
Biological properties
In vitro studies in hFOB 1.19 cells
  Human  fetal  osteoblast  cells  were  used  for  the 
assessment  of  the  biocompatibility  of  the  bioglass 
powder  in  vitro  study  and  the  hFOB  1.19  cells  were 
selected for culturing due to their relatively high growth 
rates  and  rapid  differentiation  into  mature  osteoblasts 
[16–18]. We have tried to focus on alkaline phosphate 
activity of osteoblastic cells cultured on bioglass due to 
the fact that one of the phenotypic markers for osteoblast 
proliferation and differentiation is alkaline phosphatase 
expression which can assay by spectrophotometry. The 
alkaline  phosphate  (AP)  activity  of  osteoblastic  cells 
(hFOB 1.19) cultured on bioglass powder was studied 
at two different temperatures, 37°C and 39.5°C, and the 
results were compared with those obtained from hFOB 
cells cultured in polystyrene plates. 
  At permissive temperatures (37°C) the temperature-
sensitive gene
 is expressed and this cell line proliferates 
rapidly, whereas
 at restrictive temperatures (39.5°C) the 
gene is not expressed
 and the cells proliferate less rapidly 
and  express  increased  alkaline
  phosphatase  activity 
and  osteocalcin  levels  relative  to  cells
 cultured  at  the 
permissive temperature [36, 37]. The AP and osteocalcin 
are two markers of osteoblastic differentiation. Therefore 
some degree hFOB
 1.19 proliferation and differentiation 
in vitro can be controlled
 by temperature and providing a 
useful model to examine the role of
 this kind of bioactive 
glass in osteoblastic differentiation. Before seeding cells 
the samples autoclaved at 150°C in a 95 % air and 5 % 
CO2 and water-saturated atmosphere for 1 h, then cooled 
at  room  temperature,  and  conditioned  in  serum-free, 
sterile Dulbecco’s modified Eagle’s medium (DMEM) 
from Gibco (Grand Island, NY) (400 ml) for 24 h. The 
conditioned samples were seeded with 1×10
5 hFOB cells 
(100 μl) from a suspension containing 1.27×10
6 cells/
ml. The cells were allowed to adhere to the samples in 
an incubator at 37°C for 60 min before the addition of 
2 ml DMEM containing the nutrient F–12 (D–MEM/
F12; Gibco, Gaithersburg, MD) medium supplemented 
with 10 % heat–inactivated fetal bovine serum (FBS) 
Table 1.  Ion concentrations of simulated body fluid (SBF) and 
human blood plasma.
Ion  Plasma (mmol/l)  SBF (mmol/l)
Na
+  142.0  142.0
K
+  5.0  5.0
Mg
+2  1.5  1.5
Ca
+2  2.5  2.5
Cl
-  103.0   147.8
HCO
3-  27  4.2
HPO4
-2  1.0  1.0
SO4
-2  0.5  0.5Bizari D., Rabiee M., Moztarzadeh F., Tahriri M., Alavi S. H., Masaeli R.
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and  penicillin–streptomycin.  After  that  for  authentic 
comparison,  the  same  amount  of  cells  was  seeded 
directly  on  the  polystyrene  plates.  The  medium  was 
changed every day until day six. On day three, half of 
the sampless were placed in another incubator at 39.5°C 
to stimulate differentiation. From cultures incubated at 
37°C, cells were harvested on days 3 and 6, while cultures 
incubated at 39°C where harvested on day 6. On day 3 
and 6, the media were removed and washed twice with 
PBS. The cells were separated from the samples by the 
freeze-thaw process using the detergent Triton X100 and 
liquid nitrogen. The retention of osteoblastic phenotype 
at days 3 and 6 were evaluated by measuring alkaline 
phosphatase  activity  using  a  colorimetric  method, 
and  monitored  by  following  absorption  at  410  nm, 
and  conversion  to  enzyme  activity  was  made  using 
the  p-nitrophenol  standard  absorption  curve,  which  is 
based on the conversion of p-nitrophenyl phosphate into 
p-nitrophenol in the presence of the alkaline phosphatase.
In vitro studies in SBF
  We  performed  in  vitro  studies  by  soaking  the 
samples in SBF at a concentration of 1 mg sample per 
milliliter of the fluid at 37°C for 5 time periods: 3 h, 
1 day, 3 day, 7 and 14 days. All the reacted solution was 
saved for Inductively Coupled Plasma atomic emission 
spectroscopy  (ICP-AES;  Varian  Co.,  USA)  analysis 
of Si, Ca and P to measure ionic concentration in the 
SBF solution. In addition, pH of the SBF solutions were 
measured by a calibrated pH meter every step and using 
a Corning pH meter 320.
Cytotoxicity evaluation
  L929 mouse fibroblast cell line (ATCC) was used for 
cytotoxicity. The cells were seeded in polystyrene plates 
enriched with Minimal Essential Medium supplemented 
with 10 % fetal bovine serum, 100 units/ml of penicillin 
and 100 μg/ml streptomycin, respectively and incubated 
at 37°C in humid atmosphere and 5 % CO2. When the 
cells attained confluency, the sterilized bioglass block 
was placed in direct contact with the cells and incubated 
for 48 h under the same condition. Negative (Ultra High 
molecular weight Poly Ethylene) and positive (copper) 
controls were used. After 48 h, the cells were observed 
under  optical  microscopy  (Nicon  E200).  Cellular 
responses were scored as 0, 1, 2 and 3 according to non-
cytotoxic, mildly cytotoxic and severely cytotoxic as per 
ISO 10993-5.
Statistical analysis
  All experiments were performed in fifth replicate. 
The results were given as means ± standard error (SE). 
Statistical  analysis  was  performed  by  using  One-way 
ANOVA and Tukey test with significance reported when 
P < 0.05. Also for investigation of group normalizing, 
Kolmogorov-Smirnov test was used.
RESULTS AND DISCUSSION
XRD analysis
  X-ray diffraction data of the bioglass is presented on 
Figure 1. The XRD patterns emphasized the predominant 
amorphous  state  of  the  internal  disorder  and  glassy 
nature of this material feature of the sample and it is 
worth mentioning that the bioglass does not show any 
crystalline states.
Thermal analysis
  Thermogravimetric  and  differential  scanning 
calorimetry of the sample were carried out to obtain the 
right sintering temperature. The DSC trace is a plot of 
heat changes of the glass as a function of temperature 
and is used to determine temperatures at which phase 
transitions occur and a TGA trace is a plot of the weight 
loss as a function of temperature. Figure 2 shows the 
TGA and DSC curves of prepared sample, dried at 70°C 
for 72 h and grinded. The first endothermic peak, which 
initiated at 55°C, corresponds to the release of physically 
adsorbed water that was not removed during drying. The 
TGA trace shows that all water and by-products from the 
polycondensation reaction were removed between 85°C 
and 150°C (17 % weight loss).
  Two others endothermic peaks, starting at 380°C, 
corresponds  to  the  pyrolysis  reaction  of  free  organic 
species and/or the release of the resulting water from the 
further condensation of silanol and P–OH groups and 
the removal of nitrate groups that are usually removed 
in  the  thermal  stabilization  process.  The  removal  of 
species at these temperatures is reflected in the weight 
loss  trace  from  TGA.  All  nitrates  were  removed  by 
560°C (a further 27 % of the total weight loss), so the 
total  weight  loss  was  44  %.  Finally,  the  exothermic 
peak  around  990°C  is  attributed  to  the  crystallization 
process  of  CaSiO3  (β-wollastonite)  and  cristobalite 
(SiO2) [15, 37], which has been found to form at higher 
temperatures in similar glasses [38, 39]. Also, a small 
endothermic  DSC  peak  centralized  at  about  1060°C 
Figure 1.  X-ray diffraction patterns for the bioglass nanopow-
der after stabilization at 700°C.
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implies that the material was fully crystalline at above 
1090°C. No significant weight loss was observed above 
700°C,  also  these  curves  confirmed  that  the  residuals 
could be removed before 700°C, thus this temperature is 
appropriate for a fully stabilization of the structure. We 
then treated prepared sample at 700°C during 24 h for 
stabilization of the sample. Thereupon the XRD pattern 
of the prepared glass after stabilization did not contain 
diffraction maxima, indicative of the internal disorder 
and the glassy nature of this bioactive glass.
FTIR analysis
  Figure  3  shows  the  FTIR  spectrum,  in  the 
500 - 4000 cm
-1 spectral range, of sample. The bioglass 
nanopowder  exhibited  five  infrared  bands  located  at: 
609, 800, 930, 1070 and 1212 cm
-1. Among these bands, 
those positioned at 800, 930, 1070 and 1212 cm
-1 are 
related to the silicate network and respectively ascribed 
to  the  Si–O  symmetric  stretching  of  bridging  oxygen 
atoms  between  tetrahedrons,  Si–O  stretching  of  non-
bridging oxygen atoms, Si–O–Si symmetric stretching, 
and the LO mode of Si–O–Si asymmetric stretching. The 
band located at 609 cm 
-1 is attributed to the asymmetric 
vibration of PO4
3- 
Textural properties
  The N2 adsorption isotherm of the bioactive glass, 
shown in Figure 4 corresponds to the type IV isotherm 
of the Brunauer-Deming-Deming-Teller theory (BDDT) 
classification. From these results one can infer that the 
pores are in mesopores size range. The textural properties 
of this bioactive glass are reported in Table2.
SEM observations
  Scanning electron microscope (SEM) was used to 
examine and estimate the bioglass particle size. SEM mic- 
rograph of the bioglass powder is shown in Figure 5. 
Figure 3.  FTIR spectrum of the bioglass nanopowder.
Figure 5.  SEM micrograph and EDS pattern of the bioglass 
powder.
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Figure 2.  TGA and DSC curves of the bioglass dried at 70°C.
Figure 4.  N2 adsorption isotherms of the as prepared sol-gel 
bioglass.
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Table 2.  Textural properties of the bioactive glass.
  BET Surface area  Pore volume  Pore size
  (m
2 g
-1)  (cm
3 g
-1)  (nm)
  137.9  0.37  15.4Bizari D., Rabiee M., Moztarzadeh F., Tahriri M., Alavi S. H., Masaeli R.
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As it can be seen in this figure, the grain size is in the 
range  of  50  -  100  nm.  However,  some  agglomerated 
particles are probably seen that these particles can be 
separated easily because we ground the sample for 10 h.
Biological evaluation
Biocompatibility evaluation
  The  biocompatibility  evaluation  of  the  formed 
glass was assessed through in vitro cell culture (hFOB 
1.19) experiments in this way we have tried to focus on 
alkaline phosphate activity of osteoblastic cells cultured 
on bioglass becauce one of the phenotypic markers for 
osteoblast  proliferation  and  differentiation  is  alkaline 
phosphatase expression. Figure 6a-c. Present a scheme 
of alkaline phosphate activity at days 3 with 37°C, 6 with 
37°C and 6 with 39.5°C, respectively. Statistical analysis 
using Student t test showed a significant difference in 
bone cell expression of AP activity in osteoblast culture 
on  the  samples  compared  with  polystyrene  plates 
(p < 0.05).
  Figure 6a shows that the bioglass sample in this 
condition  expressed  significantly  higher  AP  activity 
at day 3 for bone cell cultures at 37°C compared with 
bone cells cultured on polystyrene plates under the same 
condition. Also, we can see these results for bioglass 
sample at day 6 at 37°C in Figure 6b. It is noticeable 
that the higher AP activity of cells cultured on bioglass 
at 39.5°C compared with cells cultured on plates at the 
same  temperature  observed  in  Figure  6c.  At  39.5°C 
the  cells  are  supposed  to  proliferate  less  rapidly  and 
start differentiation. At permissive temperatures (37°C) 
the  temperature-sensitive  gene
  is  expressed  and  this 
cell  line  proliferates  rapidly,  whereas
  at  restrictive 
temperatures  (39.5°C)  the  gene  is  not  expressed
 and 
the cells proliferate less rapidly and express increased 
alkaline
 phosphatase activity which means starting diffe-
rentiation  [36,  37].  The  AP  and  osteocalcin  are  two 
markers of osteoblastic differentiation. Therefore some 
degree  hFOB
 1.19  proliferation  and  differentiation  in 
vitro can be controlled
 by temperature and providing a 
useful model to examine the role of
 this kind of bioactive 
glass in osteoblastic differentiation.
  A  general  conclusion  drawn  from  data  at  hand 
is  that  the  higher  alkaline  phosphate  activity  of  cells 
grown on this bioglass at 39.5°C compared with cells 
grown on polystyrene plates under the same condition 
strongly  indicate  that  high  bioactivity  in  this  kind  of 
ternary system bioactive glass stimulates early bone cell 
differentiation. In addition gene regulation response for 
bone cell differentiation among surface chemistry and 
energy in this bioglass is incisive at early stages of cell–
surface interactions and this investigation testifies that 
we could synthesis a high bioactive bioglass. 
Cytotoxicity evaluation
  As it is seen in Figure 7, bioglass sample did not 
show any signs of toxicity after 48 h with L929 cells. The 
cells appeared spindle in shape and formed a monolayer. 
The cytotoxic scale was measured as zero, which corres-
ponds to non-cytotoxicity.
Figure  6.    Comparison  of  alkaline  phosphatase  activity  of 
hFOB 1.19 cells cultured on bioactive glass powder and poly-
styrene plates.
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Changes in SBF composition
  Figure 8 shows the variations of Si, Ca, P concen-
tration  along  with  pH  values  in  the  SBF  solution  for 
various  periods,  measured  by  ICP–AES,  versus  soa-
king  time,  respectively.  When  a  glass  reacts  with  si-
mulated body fluid (SBF), both chemical and structural 
changes  occur  as  a  function  of  time  within  the  glass 
surface
 [42]  and  accumulation  of  dissolution  products 
causes both the chemical composition and pH of solu- 
tion to change. So with these variations we can investi-
gate  bioactivity  and  its  mechanism  in  (64  %  SiO2  -
31 % CaO - 5 % P2O5) nanopowder bioactive glass. 
  As can be observed in all cases, P concentration in 
the solution decreased during the first hours of soaking, 
which shows that there was a phosphorous uptake by 
the glass surface and then decreased again continuously 
until  day  3  and  after  that  no  significant  change  took 
place until day 7. In addition, pH Variation with time 
increased up to 8 during the first 7 days of immersion 
and then pH increased slowly up to 8.3 until day 14. Also 
Ca and Si concentrations, after a maximum at 7 days, 
gradually  decreased  up  to  14  days. These  changes  in 
SBF composition are depend on 5 chemical stages in the 
process of formation HCA layer on the surface of ternary 
system bioactive glass, which Hench has described them 
[14, 42, 43].
  In the first stage a rapid exchange between Ca
2+ with 
H
+ or H3O
+ from solution occurred, that is a diffusion 
Figure 7.  Optical micrograph of fibroblast cells in direct con-
tact with bioglass.
Figure 8.  Variation of elemental concentration and pH in the SBF with soaking time for silicon (a), calcium (b), phosphorus (c) 
and pH (d).
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controlled  step,  and  causing  hydrolysis  of  the  silica 
groups, which creates silanol groups. When this action 
occurs, the pH of the solution increases, as a result of H
+ 
ions in the solution being replaced by cations, so we can 
see increasing the Ca
2+ level with time also, the pH up 
to 8 during the first 7 days of immersion in SBF, which 
is related to control by both the release of Ca
2+ from the 
bioglass nanopowder and the formation of phosphate or 
apatite.
  In the second stage the cation exchange increases 
the hydroxyl concentration of the solution, which leads 
to attack of the silica glass network. Soluble silica is lost 
in the form of Si(OH)4 to the solution, resulting from the 
breaking of Si–O–Si bonds and the continued formation 
of Si–OH (silanols) at the glass solution interface [44, 
45]:
Si–O–Si + H2O → Si–OH + OH–Si           (1)
  During  3  days  that  this  stage  on  the  surface  of 
bioglass  occurred,  Si  concentration  increased  up,  and 
then no significant change took place until 7 days. When 
third stage occurred, Condensation and repolymerisation 
of a SiO2–rich layer on the surface exhaust alkalis and 
alkali-earth cations. So, after a maximum at 7 days, Ca 
and Si concentrations gradually decreased up at 14 days. 
In addition, the pH level increased slowly up to 8.3 at 
14 days. After that Ca
2+ and PO4
3- groups migrate to the 
surface  through  the  SiO2–rich  layer,  forming  a  CaO–
P2O5–rich film on top of the SiO2–rich layer, followed 
by  growth  of  the  amorphous  CaO–P2O5–rich  film  by 
incorporation of soluble calcium and phosphates from 
solution as the fourth stage. Therefore, Ca and P ions 
levels changed around the day 7. The decrease in the Ca
2+ 
concentration in SBF is attributed to the rapid growth 
of the apatite nuclei formed on surface of the glass that 
overcame the release rate of calcium ions to the solution 
[44,  45].  Finally,  forming  hydroxy  carbonate  apatite 
(HCA) layer occurred on the top of the bioglass surface 
because of crystallization of the amorphous CaO–P2O5 
film by incorporation of OH
- and CO3
2- anions from the 
SBF solution [45].
  It is worth mentioning that the bioglass released Ca 
and Si ions very quickly, due to the formation of HCA 
on bioactive glass and the release of soluble silicon and 
calcium ions to the surrounding SBF environment are 
key factors in the rapid bonding of this nanopowder to 
bone tissue as a high bioactive glass [45-50].
CONCLUSION
  Bioactive glass nanopowder was synthesized suc-
cessfully  via  a  sol-gel  method  that  the  processing  is 
simple, low cost and highly efficient. The bioactive glass 
was performed in new formulation with the molar com-
position 64 % SiO2 - 31 % CaO - 5 % P2O5 as a bioactive 
material.  Thermogravimetric  and  differential  scanning 
calorimetry of the sample were carried out to obtain the 
right sintering temperature that was 700°C. In addition, 
SEM micrograph of the bioglass powder is shown that 
the grain size of bioglass is in the nanoscale range.
  For studying in vitro bioactivity in SBF, it is men-
tionable that the bioglass released Ca and Si ions very 
quickly, due to the formation of HCA on bioactive glass 
and the release of soluble silicon and calcium ions to 
the surrounding SBF environment are key factors in the 
rapid bonding of this nanopowder to bone tissue as a high 
bioactive glass. Also, a general conclusion on in vitro 
studies on hFOB 1.19 cells which drawn from data at 
hand is that the higher alkaline phosphate activity of cells 
grown on this bioglass at 39.5°C compared with cells 
grown on polystyrene plates under the same condition 
strongly  indicate  that  high  bioactivity  in  this  kind  of 
ternary system bioactive glass stimulates early bone cell 
differentiation. Eventually, gene regulation response for 
bone cell differentiation among surface chemistry and 
energy in this bioglass is incisive at early stages of cell–
surface interactions and this investigation testifies that 
we could synthesis a high bioactive bioglass.
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